Breaking News

Argonaut Expands Drug Product Fill-Finish Capabilities

New filling line is expected to be GMP-ready for clinical and commercial business in the first half of 2025.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities. In addition to increased capacity and scale, the new capabilities include complex formulation of parenteral drug products and a new state of the art isolator-based filling line c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters